Cholangiocarcinoma: three different entities based on location.
作者信息
Aquina Christopher T, Pawlik Timothy M, Ejaz Aslam
机构信息
Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
出版信息
Ann Transl Med. 2020 Jun;8(12):738. doi: 10.21037/atm.2020.03.167.
Abstract
摘要
相似文献
1
Cholangiocarcinoma: three different entities based on location.胆管癌：基于位置的三种不同类型。
Ann Transl Med. 2020 Jun;8(12):738. doi: 10.21037/atm.2020.03.167.
2
Differential CT features of intraductal biliary metastasis and double primary intraductal polypoid cholangiocarcinoma in patients with a history of extrabiliary malignancy.有胆管外恶性肿瘤病史患者的导管内胆管转移与双原发性导管内息肉样胆管癌的CT鉴别特征。
AJR Am J Roentgenol. 2009 Oct;193(4):1061-9. doi: 10.2214/AJR.08.2089.
3
Mimics of cholangiocarcinoma: spectrum of disease.胆管癌的模仿者：疾病谱
Radiographics. 2008 Jul-Aug;28(4):1115-29. doi: 10.1148/rg.284075148.
4
Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?肝内、肝门周围及肝外胆管癌：同一肿瘤的三个不同部位还是三种不同肿瘤？
Eur J Surg Oncol. 2015 Sep;41(9):1162-9. doi: 10.1016/j.ejso.2015.05.013. Epub 2015 Jun 10.
5
Imaging mimickers of cholangiocarcinoma: a pictorial review.胆管细胞癌的影像学表现：影像学表现及鉴别诊断。
Abdom Radiol (NY). 2022 Mar;47(3):981-997. doi: 10.1007/s00261-021-03399-9. Epub 2022 Jan 3.
6
Cholangiocarcinoma: classification, diagnosis, staging, imaging features, and management.胆管癌：分类、诊断、分期、影像学特征和治疗。
Abdom Radiol (NY). 2017 Jun;42(6):1637-1649. doi: 10.1007/s00261-017-1094-7.
7
Investigation of a Tumor Location-Specific Therapeutic Strategy for Intrahepatic Cholangiocarcinoma.针对肝内胆管癌的肿瘤定位特异性治疗策略的研究。
Asian Pac J Cancer Prev. 2021 May 1;22(5):1485-1493. doi: 10.31557/APJCP.2021.22.5.1485.
8
Clinical diagnosis and staging of cholangiocarcinoma.胆管癌的临床诊断和分期。
Nat Rev Gastroenterol Hepatol. 2011 Aug 2;8(9):512-22. doi: 10.1038/nrgastro.2011.131.
9
Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.评估肝门周围胆管癌的淋巴结状态：位置、数量或受累淋巴结的比例。
Ann Surg. 2013 Apr;257(4):718-25. doi: 10.1097/SLA.0b013e3182822277.
10
Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver.细胞角蛋白谱与肝内胆管癌的组织学亚型、肝内位置以及肝转移性腺癌的原发部位相关。
Histopathology. 2000 Jul;37(1):55-63. doi: 10.1046/j.1365-2559.2000.00932.x.
引用本文的文献
1
Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma.泛素连接酶 E2C（UBE2C）是胆管癌的预后指标。
Eur J Med Res. 2023 Dec 15;28(1):593. doi: 10.1186/s40001-023-01575-9.
2
Generation of An Induced Pluripotent Stem Cell Line from Human Liver Fibroblasts from A Patient with Combined Hepatocellular-Cholangiocarcinoma.从一名肝细胞-胆管癌合并患者的人肝成纤维细胞中生成诱导多能干细胞系
Cell J. 2022 Mar;24(3):133-139. doi: 10.22074/cellj.2022.7765.
本文引用的文献
1
Cholangiocarcinoma: anatomical location-dependent clinical, prognostic, and genetic disparities.胆管癌：解剖学位置相关的临床、预后及基因差异
Ann Transl Med. 2019 Dec;7(23):744. doi: 10.21037/atm.2019.12.37.
2
A Study on Radial Margin Status in Resected Perihilar Cholangiocarcinoma.肝门周围胆管癌切缘状态的研究。
Ann Surg. 2021 Mar 1;273(3):572-578. doi: 10.1097/SLA.0000000000003305.
3
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.卡培他滨对比观察用于可切除胆管癌（BILCAP）：一项随机、对照、多中心、3 期研究。
Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25.
4
Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis.可切除性肝内胆管细胞癌是否需要进行淋巴结清扫？系统评价和荟萃分析。
HPB (Oxford). 2019 Jul;21(7):784-792. doi: 10.1016/j.hpb.2018.12.011. Epub 2019 Mar 14.
5
Cholangiocarcinoma - evolving concepts and therapeutic strategies.胆管癌——不断演变的概念与治疗策略
Nat Rev Clin Oncol. 2018 Feb;15(2):95-111. doi: 10.1038/nrclinonc.2017.157. Epub 2017 Oct 10.
6
Intrahepatic, perihilar and distal cholangiocarcinoma: Management and outcomes.肝内、肝门周围及肝外胆管癌：治疗与预后
Ann Hepatol. 2017;16(1):133-139. doi: 10.5604/16652681.1226927.
7
Resection margin influences survival after pancreatoduodenectomy for distal cholangiocarcinoma.切缘影响远端胆管癌胰十二指肠切除术后的生存率。
Am J Surg. 2017 Jun;213(6):1072-1076. doi: 10.1016/j.amjsurg.2016.09.049. Epub 2016 Oct 8.
8
Influence of surgical margins on overall survival after resection of intrahepatic cholangiocarcinoma: A meta-analysis.手术切缘对肝内胆管癌切除术后总生存期的影响：一项荟萃分析。
Medicine (Baltimore). 2016 Aug;95(35):e4621. doi: 10.1097/MD.0000000000004621.
9
Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.意大利多中心分析：肝门部胆管癌肝切除术后淋巴结状态与生存的关系。
JAMA Surg. 2016 Oct 1;151(10):916-922. doi: 10.1001/jamasurg.2016.1769.
10
Perihilar Cholangiocarcinoma: Number of Nodes Examined and Optimal Lymph Node Prognostic Scheme.肝门部胆管癌：检查的淋巴结数量及最佳淋巴结预后方案
J Am Coll Surg. 2016 May;222(5):750-759.e2. doi: 10.1016/j.jamcollsurg.2016.02.012. Epub 2016 Feb 26.
Zotero 插件